On March 5, 2018 Syros Pharmaceuticals (NASDAQ:SYRS), a biopharmaceutical company pioneering the development of medicines to control the expression of genes, reported that its Chief Executive Officer, Nancy Simonian, M.D., will present a corporate overview at upcoming investor conferences (Press release, Syros Pharmaceuticals, MAR 5, 2018, View Source [SID1234524370]). Details are as follows:

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

(Cowen and Company 38th Annual Health Care Conference
Date: Monday, March 12
Time: 12:00 p.m. ET
Location: The Boston Marriott Copley Place, 110 Huntington Avenue, Boston, MA

Oppenheimer 28th Annual Healthcare Conference
Date: Wednesday, March 21
Presentation Time: 2:10 p.m. ET
Location: The Westin New York Grand Central, 212 East 42nd Street, New York, NY

A live webcast of each presentation will be available on the Investors & Media section of the Syros website at www.syros.com. An archived replay of the webcast will be available for approximately 30 days following each presentation.

On March 5, 2018 pSivida Corp. (NASDAQ:PSDV) (ASX:PVA), a leader in the development of sustained release drug products and technologies, announced today that Nancy Lurker, President and Chief Executive Officer, is scheduled to present an overview of the Company and its progress at the 30th Annual ROTH Conference on Monday, March 12, 2018, at 5:00 p.m. ET (Press release, pSivida, MAR 5, 2018, View Source [SID1234524369]). The conference will be held at the Ritz Carlton, Laguna Nigel in Orange County, CA.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live audio and/or webcast and subsequent archived replay of pSivida’s presentation may be accessed via the Investors section of the Company’s website under "Resources – Events & Presentations" at www.psivida.com. The replay will be available for 90 days after the event.

On March 5, 2018 Genocea Biosciences, Inc. (NASDAQ:GNCA), a biopharmaceutical company developing neoantigen cancer vaccines, reported that Chip Clark, president and chief executive officer, will present a corporate overview at two upcoming investor conferences (Press release, Genocea Biosciences, MAR 5, 2018, View Source [SID1234524368]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

and Company 38th Annual Health Care Conference
Monday, March 12, 2018Cowen at 11:20 AM ET in Boston, Massachusetts
Needham & Co. Annual Healthcare Conference
Tuesday, March 27, 2018 at 10:30 AM ET in New York, New York

A live webcast of both presentations can be accessed by visiting the "Events and Presentations" tab of the investor relations section of the Genocea website at View Source A replay of the webcasts will be archived for 30 days following the conference.

On March 5, 2018 BeiGene, Ltd. (NASDAQ:BGNE), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly targeted and immuno-oncology drugs for the treatment of cancer, reported that the company will present at two upcoming investor conferences (Press release, BeiGene, MAR 5, 2018, View Sourcephoenix.zhtml?c=254246&" target="_blank" title="View Sourcephoenix.zhtml?c=254246&" rel="nofollow">View Source;p=RssLanding&cat=news&id=2336089 [SID1234524365])

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The Cowen and Company 38th Annual Health Care Conference in Boston on Monday, March 12, at 2:10 p.m. (ET); and
The Barclays Global Healthcare Conference 2018 in Miami on Wednesday, March 14, at 4:20 p.m. (ET).
Live webcasts can be accessed from the investors section of BeiGene’s website at View Source and archived replays will be available for 90 days following each event.

On March 5, 2018 Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, reported that the company is scheduled to present at the Cowen 38th Annual Healthcare Conference in Boston on Monday, March 12, 2018 at 11:20 a.m. ET (Press release, Agios Pharmaceuticals, MAR 5, 2018, http://investor.agios.com/news-releases/news-release-details/agios-present-cowen-38th-annual-healthcare-conference-monday [SID1234524364]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live webcast of the presentation can be accessed under "Events & Presentations" in the Investors section of the company’s website at www.agios.com. A replay of the webcast will be archived on the Agios website for at least two weeks following the presentation.